Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function

Cancer Prevention Research

Volumn 7, Issue 11, 2014, Pages 1149-1159

  Pan, Jing ^a   Zhang, Qi ^a   Liu, Qian ^a   Komas, Steven M ^a   Kalyanaraman, Balaraman ^a   Lubet, Ronald A ^b   Wang, Yian ^a   You, Ming ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; HONOKIOL; N NITROSO TRISCHLOROETHYLUREA; PROTEIN P63; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; BIPHENYL DERIVATIVE; CARMUSTINE; CASPASE 3; CASPASE 7; GREEN FLUORESCENT PROTEIN; LIGNAN; N-NITROSO-TRIS-CHLOROETHYLUREA; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRONCHUS DISEASE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHRONOTHERAPY; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PHENOTYPE; STAINING; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; ANIMAL; BRONCHUS; CANCER TRANSPLANTATION; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; LUNG NEOPLASMS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BIPHENYL COMPOUNDS; BRONCHI; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CARMUSTINE; CASPASE 3; CASPASE 7; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; HUMANS; LIGNANS; LUNG NEOPLASMS; MICE; MITOCHONDRIA; NEOPLASM TRANSPLANTATION; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84910118566     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0091     Document Type: Article

References (38)

1. Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis 2000;21:525-30.
2. Lippman SM, Lee JJ, Sabichi AL. Cancer chemoprevention: progress and promise. J Natl Cancer Inst 1998;90:1514-28.
3. Kelloff GJ, Sigman CC, Greenwald P. Cancer chemoprevention: progress and promise. Eur J Cancer 1999;35:2031-8.
4. Xu HL, Tang W, Du GH, Kokudo N. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discov Ther 2011;5:202-10.
5. Chiang CK, Sheu ML, Hung KY, Wu KD, Liu SH. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int 2006;70:682-9.
6. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 2003;475:19-27.
7. Cohen MH, Williams GA, Sridhara R, Chen G, McGuinn WD Jr, Morse D, et al. United States Food and Drug Administration Drug approval summary: Gefitinib (ZD1839; Iressa) tablets. Clin Cancer Res 2004;10:1212-8.
8. Liou KT, Lin SM, Huang SS, Chih CL, Tsai SK. Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats. Planta Med 2003;69:130-4.
9. Tsai SK, Huang SS, Hong CY. Myocardial protective effect of honokiol: an active component in Magnolia officinalis. Planta Med 1996;62:503-6.
10. Hoi CP, Ho YP, Baum L, Chow AH. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia of fi cinalis, on beta-amyloidinduced toxicity in PC12 cells. Phytother Res 2010;24:1538-42.
11. Lin YR, Chen HH, Ko CH, Chan MH. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 2006;537:64-9.
12. Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L, et al. Honokiol: a non-adipogenic PPARgamma agonist from nature. Biochim Biophys Acta 2013;1830:4813-9.
13. Wang X, Duan X, Yang G, Zhang X, Deng L, Zheng H, et al. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One 2011;6:e18490.
14. Wolf I, O'Kelly J, Wakimoto N, Nguyen A, Amblard F, Karlan BY, et al. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 2007;30:1529-37.
15. Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008;121:501-8 e3.
16. Jiang QQ, Fan LY, Yang GL, Guo WH, Hou WL, Chen LJ, et al. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. BMC Cancer 2008;8:242.
17. Wang Y, Zhang Z, Yan Y, Lemon WJ, LaRegina M, Morrison C, et al. A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Res 2004;64:1647-54.
18. Wang Y, Zhang Z, Garbow JR, Rowland DJ, Lubet RA, Sit D, et al. Chemoprevention of lung squamous cell carcinoma in mice by a mixture of Chinese herbs. Cancer Prev Res 2009;2:634-40.
19. Wang Y, Rouggly L, You M, Lubet R. Animal models of lung cancer characterization and use for chemoprevention research. Prog Mol Biol Transl Sci 2012;105:211-26.
20. Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W, et al. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 2003;278:37832-9.
21. Saybasili H, Yuksel M, Haklar G, Yalcin AS. Effect of mitochondrial electron transport chain inhibitors on superoxide radical generation in rat hippocampal and striatal slices. Antioxid Redox Signal 2001;3:1099-104.
22. Pan J, Zhang Q, Li K, Liu Q, Wang Y, You M. Chemoprevention of lung squamous cell carcinoma by ginseng. Cancer Prev Res 2013;6:530-9.
23. Wang Y, James M, Wen W, Lu Y, Szabo E, Lubet RA, et al. Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice. Mol Cancer Ther 2010;11:3074-82.
24. Cheng G, Zielonka J, Dranka BP, McAllister D, Mackinnon AC Jr, Joseph J, et al. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res 2012;72:2634-44.
25. Singh T, Prasad R, Katiyar SK. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. Epigenetics 2013;8:54-65.
26. Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, Tsien RY, et al. Investigating mitochondrial redox potential with redoxsensitive green fluorescent protein indicators. J Biol Chem 2004;279:13044-53.
27. Meyer AJ, Dick TP. Fluorescent protein-based redox probes. Antioxid Redox Signal 2010;13:621-50.
28. Klimova TA, Bell EL, Shroff EH, Weinberg FD, Snyder CM, Dimri GP, et al. Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS. FASEB J 2009;23:783-94.
29. Hail N Jr. Mitochondria: a novel target for the chemoprevention of cancer. Apoptosis 2005;10:687-705.
30. Hail N Jr., Lotan R. Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state. Mol Nutr Food Res 2009;53:49-67.
31. Fu H, He J, Mei F, Zhang Q, Hara Y, Ryota S, et al. Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E). Cancer Prev Res 2009;2:531-7.
32. Zhang Q, Fu H, Pan J, He J, Ryota S, Hara Y, et al. Effect of dietary polyphenon E and EGCG on lung tumorigenesis in A/J Mice. Pharm Res 2010;27:1066-71.
33. Ponnurangam S, Mammen JM, Ramalingam S, He Z, Zhang Y, Umar S, et al. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol Cancer Ther 2012;11:963-72.
34. Lai CS, Tsai ML, Cheng AC, Li S, Lo CY, Wang Y, et al. Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane-treated mice. Mol Nutr Food Res 2011;55:278-90.
35. Yuan Z, Liu H, Yan F, Wang Y, Gou L, Nie C, et al. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene. Cancer Sci 2009;100:1757-66.
36. Garcia-Ruiz I, Solis-Munoz P, Fernandez-Moreira D, Munoz-Yague T, Solis-Herruzo JA. Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain. BMC Biol 2013;11:88.
37. Hahm ER, Singh SV. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 2007;6:2686-95.
38. Hail N Jr, Cortes M, Drake EN, Spallholz JE. Cancer chemoprevention: a radical perspective. Free Radic Biol Med 2008;45:97-110.